Evidence map›Paper›PMID 27633343›Full record

ArticleScientific reports2016

Entinostat up-regulates the CAMP gene encoding LL-37 via activation of STAT3 and HIF-1α transcription factors.

Erica Miraglia, Frank Nylén, Katarina Johansson, Elias Arnér, Marcus Cebula, Susan Farmand, Håkan Ottosson, Roger Strömberg, Gudmundur H Gudmundsson, Birgitta Agerberth and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Update on antimicrobial peptides: key elements inThe Journal of general virology · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. A mouse model for vitamin D-induced human cathelicidin antimicrobial peptide gene expression.The Journal of steroid biochemistry and molecular biology · 2020
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Erica MiragliaDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Frank NylénDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Katarina JohanssonDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Elias ArnérDepartment of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
Marcus CebulaInstitute of Environmental Medicine, Division of Biochemical Toxicology, Karolinska Institutet, Stockholm, Sweden.
Susan FarmandDepartment of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Håkan OttossonDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Roger StrömbergDepartment of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.
Gudmundur H GudmundssonBiomedical Center, University of Iceland, Reykjavík, Iceland.
Birgitta AgerberthDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Peter BergmanDepartment of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Karolinska Institutet · SEUniversity of Iceland · IS

Funding

Redox regulation in the hepatostatR21AG055022 · NIA · MONTANA STATE UNIVERSITY - BOZEMAN · PI ARNER, ELIAS S.J., NAGY, PETER · 2016 to 2017
$382k
NIA NIH HHS R21 AG055022
6 · The paper itself

Abstract

Bacterial resistance against classical antibiotics is a growing problem and the development of new antibiotics is limited. Thus, novel alternatives to antibiotics are warranted. Antimicrobial peptides (AMPs) are effector molecules of innate immunity that can be induced by several compounds, including vitamin D and phenyl-butyrate (PBA). Utilizing a luciferase based assay, we recently discovered that the histone deacetylase inhibitor Entinostat is a potent inducer of the CAMP gene encoding the human cathelicidin LL-37. Here we investigate a mechanism for the induction and also find that Entinostat up-regulates human β-defensin 1. Analysis of the CAMP promoter sequence revealed binding sites for the transcription factors STAT3 and HIF-1α. By using short hairpin RNA and selective inhibitors, we found that both transcription factors are involved in Entinostat-induced expression of LL-37. However, only HIF-1α was found to be recruited to the CAMP promoter, suggesting that Entinostat activates STAT3, which promotes transcription of CAMP by increasing the expression of HIF-1α. Finally, we provide in vivo relevance to our findings by showing that Entinostat-elicited LL-37 expression was impaired in macrophages from a patient with a STAT3-mutation. Combined, our findings support a role for STAT3 and HIF-1α in the regulation of LL-37 expression.

Indexed as

Antimicrobial Cationic PeptidesBenzamidesCathelicidinsGenes, ReporterHEK293 CellsHistone Deacetylase InhibitorsHT29 CellsHumansHypoxia-Inducible Factor 1, alpha SubunitJob SyndromeLeukocytes, MononuclearLuciferasesMacrophagesPrimary Cell CulturePromoter Regions, GeneticProtein BindingAntimicrobial Cationic PeptidesBenzamidesCathelicidinsentinostatHIF1A protein, humanHistone Deacetylase InhibitorsHypoxia-Inducible Factor 1, alpha SubunitLuciferasesPyridinesRNA, Small InterferingSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID27633343
PMCPMC5025742
OpenAlexW2520414580

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.